One of the better-quality companies in the pharmaceutical sector, AbbVie ( ABBV 2.35%) had a phenomenal year in 2025.

The company’s adjusted earnings per share of $1.88 beat analyst expectations, but revenue of $22.21 billion was slightly ...

Many market players felt the company was guilty by (apparent) association with legacy technology.

Healthcare Investors is rated a Buy due to solid fundamentals and a strong distribution. Learn more about HQH stock here.

Palantir Technologies (PLTR) stock should be on your radar. Here’s why – it is currently trading within the support range ...

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face ...

Even though these out-of-favor stocks might see their stock prices go lower and quiet for a little while, sometimes their fundamentals keep pushing higher under the radar and the broader macroeconomic ...

What Is a Stock Split and How Does It Affect Shareholders? Learn how it works, and what happens to your shares, dividends, ...

Esteemed American financier Peter Lynch imparted some key investment wisdom, underscoring the significance of patience, basic arithmetic, and a keen focus on a company’s fundamentals. What Happened: ...

A demanding market couldn't forgive the company for missing on quarterly sales guidance.